# Frank A. Bonsal

> Frank A. Bonsal is a Series A investor at Red Abbey Venture Partners backing Software. See 24 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Red Abbey Venture Partners](https://shizune.co/investors/profile/red-abbey-venture-partners)
- Location: Baltimore, United States
- Total investments: 24
- Last investment: Jul 2013
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/frankbonsaljr
- X (Twitter): https://twitter.com/BonsalCapital

Frank A. Bonsal is a Series A investor at Red Abbey Venture Partners in Baltimore focused on Software and Education. Mr. Bonsal has been an active advisor to Outcome Capital since its inception in 1998. Mr. Bonsal is a Co-Founder and General Partner at New Enterprise Associates, one of the country’s largest venture capital firms. NEA invests in early-stage companies and works with management to nurture and build companies of real and lasting value. His investmentactivities focus on a broad range of technical and service-oriented companies. Mr. Bonsal is a member of the Board of Trustees of the Johns Hopkins Hospital and a member of the Johns Hopkins Hospital Endowment Board. Also, Mr. Bonsal serves on the Boards of Directors of Ceratech, CIBERNET Corporation, and COVEGA Corporation, as well as an investment advisory firm, Brown Investment Advisory and Trust Co. Before co-founding NEA, Mr. Bonsal was a general partner of Alex. Brown & Sons.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $300k–$2M |
| Series A | $1.6M–$10M |
| Series B | $5.6M–$27M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 7 | 29% |
| Education | 7 | 29% |
| Health Care | 5 | 21% |
| Medical Device | 4 | 17% |
| Medical | 3 | 13% |

55 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 15 | 63% |
| Seed | 3 | 13% |
| Series B | 3 | 13% |
| Debt Financing | 2 | 8% |
| Funding Round | 1 | 4% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 20 | 83% |
| Canada | 1 | 4% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Adlumin | Adlumin empowers modern organizations with advanced technology and top talent for cybersecurity and efficient IT operations. Adlumin was founded with the mission of addressing this challenge through the provision of a platform that proactively identifies the most recent vulnerabilities being exploited and swiftly responds to them in real-time.With the backing of an exceptional team of experts, Adlumin serves as a dedicated partner throughout the entire process, guiding users every step of the way. | $300K | Seed | Oct 28, 2016 |  |
| Cohero Health | Cohero Health offers a proprietary connected health platform for those with respiratory illness. Its sensor-based technology and engaging platform improve medication adherence and care coordination between patients and their care providers.The company offers a suite of tools and technology comprises form flexible inhaler sensors, mobilespirometers, to track real-time adherence and lung function, and a mobile application accessible on iPhone, iWatch, and Android. Cohero Health was founded in 2013 and is headquartered in New York. | $2M | Seed | Dec 22, 2015 |  |
| ZeroFox | ZeroFox provides external cybersecurity solutions to help organizations identify, manage, and mitigate social media-based cyber threats. Its solutions protect organizations from the risks introduced by social networking and digital communication platforms. In an age of constant connectivity and social sharing, users have become the primary targetfor the adversary. By continuously monitoring social platforms for cyber attacks, information loss, social engineering campaigns, account compromise, and fraud, ZeroFox protects organizations from the next generation of digital threats. Leveraging cutting-edge technology and proven security practices, ZeroFox provides both targeted protection and global insights into the world of social media threats. | $27M | Series B | Dec 03, 2015 |  |
| Citelighter | Citelighter is a virtual highlighter that automates the research and paper writing process. It allows the user to find and capture unique facts online, automatically generate citations, and write better quality papers in less time. Citelighter offers functionality to assist in creating project outlines, aggregating personalized content, as wellas automates the reference or bibliography process. Additionally, captured facts are indexed and offered to users via Citelighter's fact-recommendation system. | $2M | Seed | Jan 07, 2015 |  |
| Traitify | Traitify is a personality data company building the personality data genome for the employment marketplace. The company uses human interaction with images to create the fastest validated talent assessments in the market. Its platform includes the fastest talent assessments in the world multiple image-based behavioral assessments that arescientifically-validated and take 90 seconds to 2 minutes to complete on a mobile device and have 95% or greater completion rates.Companies use their platform to create a great candidate and employee experiences. Imagine giving value back to the candidates in the talent pool by making personalized recommendations for what job to apply for. Or generating personalized content to share back with candidates to create ongoing engagement, all based on their unique personality traits. Companies with great employment brands create reciprocity with candidates and employees alike. | $4M | Series A | Jul 08, 2014 |  |
| RedOwl | RedOwl provides proactive risk oversight software solutions for compliance, insider threat, and investigations. It provides an unparalleled context by combining human-centric data, delivering situational awareness to identify and disrupt espionage, IP theft, compromised users, and rogue employees.It was founded in 2011 and headquartered inBaltimore, Maryland. | $11M | Series A | Jun 24, 2014 |  |
| VirtaMove | Automating onboarding and deployment of server applications to private, public, and hybrid clouds, VirtaMove modernizes Windows Server applications in days instead of months. VirtaMove can move applications to the cloud and to a new version of an OS at the same time. VirtaMove is the fastest and most flexible way to move workloads across cloudsand datacenter servers, without re-engineering, re-installation, or lock-in.VirtaMove containerizes and moves Windows production server applications from a source machine – physical or virtual – to any destination server, in any cloud or datacenter. It separates an application from the operating system and machine, copies it and reinstalls the application on a new machine. This approach allows you to modernize [upgrade] the operating system and move to the cloud in one step. | $3M | Series A | Mar 05, 2014 |  |
| GrayBug | GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro – and nanoparticle controlled release technologies and implants for strategic partnership and itsown therapeutic products for major ocular disease indications including wet AMD and Glaucoma.The company was founded in 2011 and headquartered in Baltimore, Maryland. | $1.5M | Series A | Oct 29, 2013 |  |
| Think Through Learning | Think Through Learning's key product line, Think Through Math, is America's leading online math remediation software. There are almost 3,000,000 students in over 180,000 classrooms who are paid subscribers to Think Through Math. Think Through Math is a unique SaaS system integrating student motivation, instant on-demand interventionsfrom state-certified US math teachers, and award winning adaptive math instruction that teaches students higher order thinking skills. Winner of the 2014 and 2012 CODiE for Best Math Instructional Solution, Think Through Math is proven to raise students understanding of math.Each student starts with an adaptive placement test that moves them right to the math they need to learn. Extensive guided feedback supports them. When they are stuck, a U.S., state-cerfiied, classroom experienced math teacher will pop up within 10 seconds to tutor them in real time. A January, 2015 independent research study commissioned by the Texas Education Agency (TEA) of 755,440 students who used Think Through Math showed that students using the system on a regular basis improved their math scores an average of 23%. The study is available of the TEA website. Numerous other studies have proven Think Through Math significantly improves students understanding of math. | $5.6M | Series B | Sep 05, 2013 |  |
| Cartiva | Cartiva is a private, venture capital-backed company that was spun out from Carticept Medical in December 2011. Cartiva is dedicated to improving the quality of life for patients with osteoarthritis or cartilage damage through the development of novel therapies. Cartiva’s mission is to develop and market products to help physicians treatosteoarthritis and cartilage injuries and the related pain more effectively. The company's management team, the board of directors, and medical advisors are comprised of industry-recognized professionals who possess broad knowledge in orthopedics and extensive experience managing innovative medical devices from development through clinical trials, FDA approval, and successful commercialization.Cartiva is located in Alpharetta, Georgia. | $4.3M | Series A | Jul 15, 2013 |  |

10 of 24 investments shown.

## Co-investors
- [New Markets Venture Partners](https://shizune.co/investors/profile/new-markets-venture-partners) — VC Fund, 6 deals together
- [TCP Venture Capital](https://shizune.co/investors/profile/tcp-venture-capital) — VC Fund, 4 deals together
- [Maryland Venture Fund](https://shizune.co/investors/profile/maryland-venture-fund) — VC Fund, 3 deals together
- [NewSchools Venture Fund](https://shizune.co/investors/profile/new-schools-venture-fund) — VC Fund, 3 deals together
- [Baltimore Angels](https://shizune.co/investors/profile/baltimore-angels) — VC Fund, 2 deals together
- [J. Hunt Holdings](https://shizune.co/investors/profile/j-hunt-holdings) — VC Fund, 2 deals together

## About Red Abbey Venture Partners

VC Fund · Baltimore, United States

Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately held and 9 publicly traded life sciences companies. Mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well ascompanies that are supporting these efforts with novel tools and products. Specifically, seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies.

2 contacts available at Red Abbey Venture Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Frank A. Bonsal | Founding Member | https://shizune.co/investors/profile/frank-a-bonsal-jr |
| Philip Goelet | Founding Member | https://shizune.co/investors/profile/philip-goelet-phd |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [EdTech Angel Investors](https://shizune.co/investors/edtech-angel-investors)
- [Education Angel Investors](https://shizune.co/investors/education-angel-investors)
- [EdTech Angel Investors in United States](https://shizune.co/investors/edtech-angel-investors-united-states)
- [Medical Device Angel Investors](https://shizune.co/investors/medical-device-angel-investors)
- [Medical Device Angel Investors in United States](https://shizune.co/investors/medical-device-angel-investors-united-states)
- [Biotech Angel Investors in United States](https://shizune.co/investors/biotech-angel-investors-united-states)

## FAQ

### What does Frank A. Bonsal invest in?

Frank A. Bonsal invests primarily in Software, Education and Health Care startups, most often at Series A and Seed stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Frank A. Bonsal's check size?

Frank A. Bonsal typically joins rounds of $300k–$2M at Seed, $1.6M–$10M at Series A and $5.6M–$27M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Frank A. Bonsal participates in.

### When did Frank A. Bonsal last invest?

The most recent investment recorded for Frank A. Bonsal closed in Jul 2013. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co